Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Bivalirudina")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 260

  • Page / 11
Export

Selection :

  • and

BivalirudineGACON, Pierre-Henry.Archives des maladies du coeur et des vaisseaux. Pratique. 2005, Num 142, pp 38-39, issn 1261-694X, 2 p.Article

Brachytherapy and bivalirudin evaluation studyKUCHULAKANTI, Pramod; WOLFRAM, Roswitha; WAKSMAN, Ron et al.The American heart journal. 2005, Vol 150, Num 4, pp 832-837, issn 0002-8703, 6 p.Article

Validation of the i-STAT handheld activated clotting time for use with BivalirudinSCHUSSLER, Jeffrey M; LANDER, Stuart R; WISSINGER, Laurie A et al.The American journal of cardiology. 2004, Vol 93, Num 10, pp 1318-1319, issn 0002-9149, 2 p.Article

A 24-hour continuous infusion study of bivalirudin in the ratGLEASON, Teresa G; CHENGELIS, Christopher P; JACKSON, Carney B et al.International journal of toxicology. 2003, Vol 22, Num 3, pp 195-206, issn 1091-5818, 12 p.Article

Heparin versus bivalirudin for carotid artery stenting using proximal endovascular clamping for neuroprotection: Results from a prospective randomized studySTABILE, Eugenio; SORROPAGO, Giovanni; TESORIO, Tullio et al.Journal of vascular surgery. 2010, Vol 52, Num 6, pp 1505-1510, issn 0741-5214, 6 p.Article

Impact of smart infusion technology on administration of anticoagulants (Unfractionated heparin, Argatroban, Lepirudin, and Bivalirudin)FANIKOS, John; FIUMARA, Karen; BAROLETTI, Steve et al.The American journal of cardiology. 2007, Vol 99, Num 7, pp 1002-1005, issn 0002-9149, 4 p.Article

Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical centerGURM, Hitinder S; RAJAGOPAL, Vivek; FATHI, Robert et al.The American journal of cardiology. 2005, Vol 95, Num 6, pp 716-721, issn 0002-9149, 6 p.Article

Value of monitoring activated clotting time when bivalirudin is used as the sole anticoagulation agent for percutaneous coronary interventionCHENEAU, Edouard; CANOS, Daniel; KUCHULAKANTI, Pramod K et al.The American journal of cardiology. 2004, Vol 94, Num 6, pp 789-792, issn 0002-9149, 4 p.Article

Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudinEICHLER, Petra; LUBENOW, Norbert; STROBEL, Ulrike et al.Blood. 2004, Vol 103, Num 2, pp 613-616, issn 0006-4971, 4 p.Article

Choix des médicaments pour traiter la thrombocytopénie induite par l'héparine = Choice of Drugs for Heparin-Induced ThrombocytopeniaThe Medical letter on drugs and therapeutics (Edition française). 2012, Vol 34, Num 13, pp 51-52, issn 0253-8512, 2 p.Article

Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched studyHAMON, Martial; RAO, Sunil V; STEG, Gabriel et al.EuroIntervention. 2012, Vol 8, Num 4, pp 486-492, issn 1774-024X, 7 p.Article

Controlled Reperfusion with Intravenous Bivalirudin and Intracoronary Abciximab Combination Therapy in the Porcine Myocardial Infarction ModelBUSZMAN, Piotr P; WOJAKOWSKI, Wojciech; GRANADA, Juan F et al.Thrombosis research. 2012, Vol 130, Num 2, pp 265-272, issn 0049-3848, 8 p.Article

Incidence of Bleeding in Renally Impaired Patients Receiving Incorrectly Dosed Eptifibatide or Bivalirudin While Undergoing Percutaneous Coronary InterventionTAYLOR, Lindsey A; MAURO, Vincent F.The Annals of pharmacotherapy. 2012, Vol 46, Num 1, pp 35-41, issn 1060-0280, 7 p.Article

Thrombin generation assay: a new tool to predict and optimize clinical outcome in cardiovascular patients?CAMPO, Gianluca; PAVASINI, Rita; POLLINA, Alberto et al.Blood coagulation & fibrinolysis. 2012, Vol 23, Num 8, pp 680-687, issn 0957-5235, 8 p.Article

Correlation of Bivalirudin Dose with Creatinine Clearance During Treatment of Heparin-Induced ThrombocytopeniaRUNYAN, Courtney L; CABRAL, Katherine P; RIKER, Richard R et al.Pharmacotherapy. 2011, Vol 31, Num 9, pp 850-856, issn 0277-0008, 7 p.Article

Effect of Clopidogrel Pretreatment on Ischemic Complications of Percutaneous Coronary Intervention Among Bivalirudin-Treated Patients (from the EVENT Registry)AMIN, Amit P; KENNEDY, Kevin F; PENCINA, Michael et al.The American journal of cardiology. 2011, Vol 107, Num 12, pp 1751-1756, issn 0002-9149, 6 p.Article

Comparison of Bivalirudin and Unfractionated Heparin Plus Protamine in Patients With Coronary Heart Disease Undergoing Percutaneous Coronary Intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] Trial)PARODI, Guido; MIGLIORINI, Angela; VALENTI, Renato et al.The American journal of cardiology. 2010, Vol 105, Num 8, pp 1053-1059, issn 0002-9149, 7 p.Article

bivalirudine (ANGIOX°) et infarctus: Pas de progrès tangible = Bivalirudin and myocardial infarct : a critical studyLa Revue Prescrire. 2010, Vol 30, Num 324, issn 0247-7750, p. 733Article

Validation of Long-Term Benefits of Bivalirudin Versus Unfractionated Heparin in Routine Clinical Practice After Percutaneous Coronary InterventionVIDI, Venkatesan D; MATHENY, Michael E; AGARWAL, Vikram et al.The American journal of cardiology. 2010, Vol 106, Num 9, pp 1234-1240, issn 0002-9149, 7 p.Article

A comparison of anticoagulation with bivalirudin and provisional GPIIb/IIIa inhibition with unfractionated heparin and mandatory GPIIb/IIIa inhibition during percutaneous coronary intervention in relation to platelet activation and the inhibition of coagulationRAY, Michael J; JUNEJA, Manjeet; BETT, Nicholas et al.EuroIntervention. 2009, Vol 5, Num 3, pp 330-335, issn 1774-024X, 6 p.Article

Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effect of unfractionated heparin and bivalirudinBADR ESTAM, Roza; REITER, Nina; KAIDER, Alexandra et al.European heart journal. 2009, Vol 30, Num 15, pp 1831-1836, issn 0195-668X, 6 p.Article

Anticoagulation in Patients with Heparin-Induced Thrombocytopenia undergoing Percutaneous Coronary Angiography and Interventions : Drugs in interventional cardiologyJOOST, Alexander; KUROWSKI, Volkhard; RADKE, Peter W et al.Current pharmaceutical design. 2008, Vol 14, Num 12, pp 1176-1185, issn 1381-6128, 10 p.Article

Bivalirudin versus Unfractionated Heparin during Percutaneous Coronary InterventionKASTRATI, Adnan; NEUMANN, Franz-Josef; MINNERS, Jan et al.The New England journal of medicine. 2008, Vol 359, Num 7, pp 688-696, issn 0028-4793, 9 p.Article

In Vitro Effects of Argatroban, Lepirudin, Bivalirudin, and Danaparoid on Fibrin Gel PermeabilitySHU HE; WALLEN, Hakan; JOHNSSON, Hans et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 91-96, issn 0094-6176, 6 p., SUP1Article

Risque hémorragique au décours des angioplasties : nouvelles stratégies thérapeutiquesCOSTE, P; GERBAUD, E; JAÏS, C et al.Archives des maladies du coeur et des vaisseaux. 2007, Vol 100, pp 36-40, issn 0003-9683, 5 p., HSArticle

  • Page / 11